CRTX — CRISM Therapeutics Share News
0.000.00%
Last trade - 00:00- £8.12m
- £7.77m
- £0.03m
Crism Therapeutics: Holding(s) in Company
Crism Therapeutics: Result of Retail Offer and Additional Placing
RCS - CRISM Therapeutics - Update presentation on the IMC platform
Crism Therapeutics: Retail Offer
Crism Therapeutics: Placing
Crism Therapeutics: Final Results for the year ended 31 December 2024
RCS - CRISM Therapeutics - Best Paper Award
Brief: CRISM Therapeutics Establishes Scientific Advisory Board
Crism Therapeutics: Director Dealing
Crism Therapeutics: Clinical Trial Update
Crism Therapeutics: European Patent Grant
Crism Therapeutics: Interim Results
Crism Therapeutics: Notice of Interim Results & IMC Presentation
RCS - CRISM Therapeutics - Delivery Method Validated in Peer Reviewed Journal
Brief: Crism Therapeutics Signs Service Agreement With Value Of £230,000
Crism Therapeutics - Response to Movement in Share Price
Crism Therapeutics - Director Dealing
Brief: Amur Minerals Corp To Buy Extruded Pharmaceuticals
Amur Minerals Corp - Proposed Reverse Takeover